Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 11377447 was granted and assigned to Madrigal Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office. | 11377447 | July 5, 2022 | |||||||
Patent 11491145 was granted and assigned to Madrigal Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office. | 11491145 | November 8, 2022 | |||||||
Patent 9968612 was granted and assigned to Madrigal Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office. | 9968612 | May 15, 2018 | |||||||
Patent 9910031 was granted and assigned to Madrigal Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office. | 9910031 | March 6, 2018 | |||||||
Patent 11090308 was granted and assigned to Madrigal Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office. | 11090308 | August 17, 2021 | |||||||
Patent 10376598 was granted and assigned to Madrigal Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office. | 10376598 | August 13, 2019 | |||||||
Patent 9956293 was granted and assigned to Madrigal Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office. | 9956293 | May 1, 2018 | |||||||
Patent 10117944 was granted and assigned to Madrigal Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office. | 10117944 | November 6, 2018 | |||||||
Patent 10232049 was granted and assigned to Madrigal Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office. | 10232049 | March 19, 2019 | |||||||
10828315 | November 10, 2020 | ||||||||
10722525 | July 28, 2020 | ||||||||
10675360 | June 9, 2020 |